...
首页> 外文期刊>Protein Expression and Purification >Recombinant fusion proteins for the industrial production of disulfide bridge containing peptides: Purification, oxidation without concatamer formation, and selective cleavage
【24h】

Recombinant fusion proteins for the industrial production of disulfide bridge containing peptides: Purification, oxidation without concatamer formation, and selective cleavage

机译:用于工业生产含二硫键的肽的重组融合蛋白:纯化,不形成前体的氧化和选择性裂解

获取原文
获取原文并翻译 | 示例

摘要

We report the biotechnical production of peptides of approximately 35-50 amino acids in length containing one intramolecular disulfide bridge, using a recombinant fusion tail approach. This method fills the technological gap when either (a) chemical synthesis fails due to known problematic peptide sequences or (b) if simple recombinant expression is unsuccessful due to degradation. The fusion tail described here serves several purposes: (i) it enables high expression levels in Escherichia coli to be achieved; (ii) it renders the fusion protein fairly soluble; (iii) it contains a histidine affinity tag for easy purification on Ni-chelate resins, which also serves as a catalyst for the oxygen-dependent formation of the disulfide bridge; and (iv) it suppresses the formation of concatamers during the oxidation process through steric hindrance. The purified fusion protein is then immobilized on a reversed phase column for two purposes: (i) chemical cleavage of the fusion tail by cyanogen bromide and (ii) subsequent purification of the peptide. A very hydrophilic fusion partner is required so that immobilization on the reversed phase column always occurs due to the peptide. Sensitive hydrophobic residues are thereby protected from the cleavage reagent while the cleaved hydrophilic fusion tail is easily separated from the hydrophobic peptide. The method is exemplified by eight peptides representing an immunodominant epitope of the human immunodeficiency virus, but may be useful for a significant variety of similar peptides. (C) 1998 Academic Press. [References: 12]
机译:我们报告了使用重组融合尾巴方法,包含一个分子内二硫键的长度约为35-50个氨基酸的肽的生物技术生产。当(a)由于已知的有问题的肽序列而导致化学合成失败或(b)如果由于降解而导致的简单重组表达不成功时,该方法填补了技术空白。此处描述的融合尾部具有多个目的:(i)使大肠杆菌中的高表达水平得以实现; (ii)使融合蛋白相当可溶; (iii)它含有一个组氨酸亲和标签,易于在镍螯合物树脂上纯化,并且还用作二硫键的氧依赖性形成的催化剂; (iv)通过空间位阻抑制氧化过程中助催化剂的形成。然后将纯化的融合蛋白固定在反相色谱柱上,用于两个目的:(i)溴化氰化学裂解融合尾,和(ii)随后纯化肽。需要非常亲水的融合伴侣,以使固定在反相色谱柱上始终由于肽而发生。从而保护敏感的疏水残基不受切割试剂的影响,同时容易将所切割的亲水融合尾部与疏水肽分离。该方法以代表人免疫缺陷病毒的免疫优势表位的八种肽为例,但对于大量相似的肽可能有用。 (C)1998年学术出版社。 [参考:12]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号